Amgen (AMGN) Revenue (2009 - 2026)

Amgen's Revenue history runs 18 years deep, the most recent figure standing at $8.6 billion for Q1 2026.

• In Q1 2026, Revenue rose 5.76% year-over-year to $8.6 billion; the TTM figure through Mar 2026 stood at $37.2 billion (up 9.07% YoY), while the FY2025 annual figure was $36.8 billion, up 9.95% from the prior year.
• Revenue was $8.6 billion for Q1 2026 at Amgen, down from $9.9 billion in the prior quarter.
• In the past five years, Revenue ranged from a high of $9.9 billion in Q4 2025 to a low of $459.0 million in Q4 2022.
• Historically, Revenue has averaged $7.5 billion across 5 years, with a median of $8.1 billion in 2025.
• The sharpest annual moves came in 2022 and 2023: Revenue sank 93.3% in 2022, then surged 1685.62% in 2023.
• A 5-year view of Revenue shows it stood at $459.0 million in 2022, then soared by 1685.62% to $8.2 billion in 2023, then climbed by 10.86% to $9.1 billion in 2024, then climbed by 8.58% to $9.9 billion in 2025, then dropped by 12.65% to $8.6 billion in 2026.
• The last three Revenue figures came in at $8.6 billion (Q1 2026), $9.9 billion (Q4 2025), and $9.6 billion (Q3 2025), per Business Quant data.